Medtronic plc (LON:0Y6X)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 88.05B |
| Revenue (ttm) | 26.58B |
| Net Income (ttm) | 3.41B |
| Shares Out | n/a |
| EPS (ttm) | 2.62 |
| PE Ratio | 25.82 |
| Forward PE | n/a |
| Dividend | 2.33 (2.63%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 225 |
| Average Volume | 5,761 |
| Open | 88.59 |
| Previous Close | 88.09 |
| Day's Range | 87.85 - 89.34 |
| 52-Week Range | 68.87 - 91.91 |
| Beta | 0.82 |
| RSI | 44.19 |
| Earnings Date | May 21, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial numbers in USD Financial StatementsNews
Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
Upgraded Medtronic to a ‘Buy' rating with a fair value of $105 per share, driven by strong growth in Cardiac Ablation Solutions and TAVR markets. Medtronic reported 4.1% organic revenue growth and 6.2...
FDA classifies recall of Medtronic embolization devices as 'most serious'
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.
Dividend Kings Of The Future
A list of 9 companies that may reach Dividend King status in the near future. These companies span various sectors and offer investors a wide range of dividend growth rates and yields. A few of these ...
Medtronic slips after FDA notice on product recall
Medtronic (MDT) Announces Transition of Principal Accounting Officer
Medtronic (MDT) Announces Transition of Principal Accounting Officer
The Big 3: KO, MDT, LHX
Stability is Kenny Polcari's theme when it comes to today's Big 3. He explains why Cola-Cola (KO), Medtronic (MDT) and L3Harris (LHX) are undervalued names with quality.
CGS Transforms Workplace Training with Cicero, a New AI-Driven, Customizable Roleplay Platform
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- CGS Immersive™, the leader in enterprise learning that is modernizing training and development with AI and XR technologies, today introduced Cicero™, a hyp...
Medtronic PLC (MDT) Announces Promising Two-Year Results from SMART Trial
Medtronic PLC (MDT) Announces Promising Two-Year Results from SMART Trial
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON ,...
Medtronic announces cash dividend for fourth quarter of fiscal year 2025
GALWAY, Ireland , March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal ye...
This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
Medtronic Launches Ambitious 10-Year Initiative to Bridge Health Tech Talent Gap
Medtronic Launches Ambitious 10-Year Initiative to Bridge Health Tech Talent Gap
Decoding Medtronic PLC (MDT): A Strategic SWOT Insight
Decoding Medtronic PLC (MDT): A Strategic SWOT Insight
Medtronic Stock Gets IBD Rating Lift
A Relative Strength Rating upgrade for Medtronic shows improving technical performance. Will it continue?
Medtronic evaluating manufacturing footprint amid higher tariffs: report
Medtronic (MDT) is reportedly looking at adjusting its global manufacturing footprint amid heightened concerns that the U.S. will impose higher tariffs on imported goods.
Medtronic PLC (MDT) Secures FDA Approval for Groundbreaking Adaptive Deep Brain Stimulation System
Medtronic PLC (MDT) Secures FDA Approval for Groundbreaking Adaptive Deep Brain Stimulation System
Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U.S. President Donald Trump's tariff plans, a company exe...
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
On Monday, the FDA approved Medtronic plc’s (NYSE: MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease . Deep brain s...
Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for personalized symptom control.
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland , Feb. 24, 2025 /...
Is Medtronic Stock a Buy?
The medical device maker has been a huge winner for its long-term shareholders.
Medtronic PLC (MDT) Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and ...
Medtronic PLC (MDT) Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and Neuromodulation Segments
Medtronic Earnings Review: Stuck In The Single Digits Again
Medtronic (MDT) Stock Declines After Q3 Earnings Report
Medtronic (MDT) Stock Declines After Q3 Earnings Report